Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2010 (2010), Article ID 267640, 5 pages
Research Article

Camptocormia in Parkinson's Disease

1Department of Nursing and Rehabilitation, Konan Women's University, Kobe 657-0001, Japan
2Department of Neurology and Rehabilitation Center, Konan Hospital, Kobe 658-0064, Japan
3Clinical Research Center, Osaka Health Science University, 1-9-27 Tenma, Kita-Ku, Osaka 530-0043, Japan
4Garacia Hospital, Rehabilitation Center, Yokosuka 562-8567, Japan

Received 13 November 2009; Revised 12 February 2010; Accepted 2 June 2010

Academic Editor: Elan D. Louis

Copyright © 2010 Kazuo Abe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Objectives. Abnormalities of posture represent one of the main features of Parkinson's disease (PD). Among them, camptocormia has been considered as rare in PD. We investigated frequency and clinical features of camptocormia in PD patients. Methods. 153 PD patients (mean 6 8 . 5 ± 1 0 . 7 years old, duration 5 . 9 ± 2 . 4 years) outpatiently recruited. After neurologic examination, patients were rated on the Unified PD Rating Scale motor scale (UPDRS Part III), minimental state examination (MMSE). Also we evaluated patients with camptocormia by MRI. Of the 153 PD patients, 27 had camptocormia (mean age, 6 7 . 9 ± 7 . 9 years old; disease duration, 6 . 1 ± 3 . 9 years). For further evaluation, we recruited age- and sex-matched 27 PD patients without camptocormia (11 men and 16 women; mean age ± S D , 6 9 . 2 ± 1 0 . 1 years, duration 6 . 0 ± 2 . 7 years) These selected 54 patients completed several self-assessments. Lumbar and thoracic paraspinal muscles were studied by EMG. Results. There were no significant differences in age, duration, severity, and drug dose between patients with and without camptocormia. Analysis of NMSS subitems indicated that PD patients tended to show lower scores for sleep/fatigue, attention/memory, and miscellaneous items. Conclusions. We found significant differences concerning nonmotor signs and symptoms evaluated by FAB, PDQ-8, FSQ, VAS-F, and NMSS between patients with and without camptocormia. Our findings indicate that camptocormia is a relatively common sign in PD and that patients with camptocormia scores on the PDQ-8 compared with PD patients without camptocormia. This suggests that improvements in camptocormia of PD patients may improve their QOL.